Molecular imaging for early response assessment of neo-adjuvant chemotherapy and drugs targeting the PI3K/Akt/mTOR pathway in HER-2 amplified breast cancer
Source
Antwerp, University of Antwerp, 2024,223 p.
Clinical impact of using [¹⁸F]AlF-NOTA-octreotide PET/CT instead of [⁶⁸Ga]Ga-DOTA-SSA PET/CT : secondary endpoint analysis of a multicenter, prospective trial
Source
Journal of neuroendocrinology - ISSN 0953-8194- (2024) p.
The metabolic and lipidomic fingerprint of Torin1 exposure in mouse embryonic fibroblasts using untargeted metabolomics
Source
Metabolites - ISSN 2218-1989-14:5 (2024) p. 1-16
Druglike, ¹⁸F-labeled PET tracers targeting fibroblast activation protein (FAP)
Source
Journal of medicinal chemistry - ISSN 0022-2623-67:9 (2024) p. 7068-7087
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
Source
NPJ breast cancer - ISSN 2374-4677-10:1 (2024) p. 1-10